CV Sciences (CVSI) Free Cash Flow (2011 - 2026)
CV Sciences' (CVSI) quarterly Free Cash Flow came in at $98000.0 in Q1 2026, up 180.99% year-on-year from $34876.5 in Q1 2025, and up 131.01% quarter-over-quarter from -$316000.0 in Q4 2025.
CV Sciences (CVSI) Free Cash Flow (2011 - 2026) Analysis & Trends
CV Sciences has disclosed Free Cash Flow across 16 years of filings, most recently posting $98000.0 for Q1 2026.
- Free Cash Flow for Q1 2026 came in at $98000.0, up 180.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$297000.0 (up 38.38% YoY), and the FY2025 annual result was -$516000.0, up 41.3% from the prior year.
- Free Cash Flow came in at $98000.0 for Q1 2026 at CV Sciences, up from -$316000.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $1.4 million in Q2 2023 to a low of -$1.2 million in Q2 2022.
- The 5-year median for Free Cash Flow is -$121000.0 (2025), against an average of -$54647.1.
- Across the five-year window, Free Cash Flow sank 542.11% in 2024 and surged 517.54% in 2025, its largest moves.
- CV Sciences' Free Cash Flow stood at $210000.0 in 2022, then plunged by 154.29% to -$114000.0 in 2023, then sank by 59.65% to -$182000.0 in 2024, then slumped by 73.63% to -$316000.0 in 2025, then soared by 131.01% to $98000.0 in 2026.
- The last three Free Cash Flow figures came in at $98000.0 (Q1 2026), -$316000.0 (Q4 2025), and -$317000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | 98,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98,000.00 |
| Mar 31, 2026 | 98,000.00 |
| Dec 31, 2025 | -316,000.00 |
| Dec 31, 2025 | -316,000.00 |
| Sep 30, 2025 | -317,000.00 |
| Sep 30, 2025 | -317,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Mar 31, 2025 | -121,000.00 |
| Mar 31, 2025 | -121,000.00 |
| Dec 31, 2024 | -182,000.00 |
| Dec 31, 2024 | -182,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Jun 30, 2024 | -57,000.00 |
| Jun 30, 2024 | -57,000.00 |
| Mar 31, 2024 | -518,000.00 |
| Mar 31, 2024 | -518,000.00 |
| Dec 31, 2023 | -114,000.00 |
| Dec 31, 2023 | -114,000.00 |